Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Live-Stream Social Media Is Hot and So Is YY Stock

By Chris Lau, InvestorPlace Contributor

YY reported strong fourth-quarter revenue and earnings. YY stock should be boosted by several positive catalysts..

The Run-Up in Altria Stock Isn’t Over Yet

By Chris Lau, InvestorPlace Contributor

Investors in Altria Group (NYSE:MO) enjoyed months of steady upside throughout much of last year, only to see the stock fall since November. But on…

The Roche Merger Will Do Wonders for Spark Stock

By Chris Lau, InvestorPlace Contributor

As Spark Therapeutics gets acquired, existing shareholders, and Roche investors, will need to eveluate the merits of the deal.

Why Amazon Stock Will Break Out of Its Trading Range

By Chris Lau, InvestorPlace Contributor

Amazon.com stock is in a holding pattern despite the company finishing the holiday quarter on a strong note. Shares are set to break out.

3 Life Sciences Stocks to Invest In

By Chris Lau, InvestorPlace Contributor

Generic drug companies are on discount for investors who want to buy life sciences stocks. Why, and when will this sector recover?

Load More